FOXD3 expression is downregulated in CP-resistant nasopharyngeal carcinoma cells and it can promote the expression of miR-26b which sensitizes nasopharyngeal carcinoma cells to CP [7]. This evidence concerns the gene FOXD3 and nasopharyngeal carcinoma.